P. Böhm and J. Huber, The surgical treatment of bony metastases of the spine and limbs, The Journal of Bone and Joint Surgery, vol.84, issue.4, pp.521-529, 2002.
DOI : 10.1302/0301-620X.84B4.12495

E. Chang, A. Shiu, and E. Mendel, Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure, Journal of Neurosurgery: Spine, vol.7, issue.2, pp.151-160, 2007.
DOI : 10.3171/SPI-07/08/151

E. Chow, K. Harris, and G. Fan, Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review, Journal of Clinical Oncology, vol.25, issue.11, pp.1423-1436, 2007.
DOI : 10.1200/JCO.2006.09.5281

S. Lutz, L. Berk, and E. Chang, Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.4, pp.965-976, 2011.
DOI : 10.1016/j.ijrobp.2010.11.026

A. Garg, X. Wang, and A. Shiu, Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy, Cancer, vol.34, issue.22 suppl, pp.3509-3516, 2011.
DOI : 10.1002/cncr.25918

X. Wang, L. Rhines, and A. Shiu, Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1???2 trial, The Lancet Oncology, vol.13, issue.4, pp.395-402, 2012.
DOI : 10.1016/S1470-2045(11)70384-9

A. Sahgal, E. Atenafu, and S. Chao, Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score, Journal of Clinical Oncology, vol.31, issue.27, pp.3426-3431, 2013.
DOI : 10.1200/JCO.2013.50.1411

F. Saad, D. Gleason, and R. Murray, A Randomized, Placebo-Controlled Trial of Zoledronic Acid in Patients With Hormone-Refractory Metastatic Prostate Carcinoma, JNCI Journal of the National Cancer Institute, vol.94, issue.19, pp.1458-1468, 2002.
DOI : 10.1093/jnci/94.19.1458

L. Rosen, D. Gordon, and W. Dugan, Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion, Cancer, vol.94, issue.1, pp.36-43, 2004.
DOI : 10.1002/cncr.11892

. Gy-vs, 6 Gy) of analgesic radiotherapy plus zoledronate in patients with bone metastases, Clin Transl Oncol, vol.10, pp.281-287, 2008.

E. Algur, R. Macklis, and U. Häfeli, Synergistic cytotoxic effects of zoledronic acid and radiation in human prostate cancer and myeloma cell lines, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.2, pp.535-542, 2005.
DOI : 10.1016/j.ijrobp.2004.09.065

M. Thurnher, O. Nussbaumer, and G. Gruenbacher, Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents, Clinical Cancer Research, vol.18, issue.13, pp.3524-3531, 2012.
DOI : 10.1158/1078-0432.CCR-12-0489

F. Dieli, N. Gebbia, and F. Poccia, Induction of ???? T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo, Blood, vol.102, issue.6, pp.2310-2311, 2003.
DOI : 10.1182/blood-2003-05-1655

F. Dieli, D. Vermijlen, and F. Fulfaro, Targeting Human ???? T Cells with Zoledronate and Interleukin-2 for Immunotherapy of Hormone-Refractory Prostate Cancer, Cancer Research, vol.67, issue.15, pp.7450-7457, 2007.
DOI : 10.1158/0008-5472.CAN-07-0199

B. Cox, D. Spratt, and M. Lovelock, International Spine Radiosurgery Consortium Consensus Guidelines for Target Volume Definition in Spinal Stereotactic Radiosurgery, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.597-605, 2012.
DOI : 10.1016/j.ijrobp.2012.03.009

R. Timmerman, An Overview of Hypofractionation and Introduction to This Issue of Seminars in Radiation Oncology, Seminars in Radiation Oncology, vol.18, issue.4, pp.215-222, 2008.
DOI : 10.1016/j.semradonc.2008.04.001

J. Kao, C. Chen, and C. Tong, Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases, Targeted Oncology, vol.55, issue.1, pp.145-153, 2014.
DOI : 10.1007/s11523-013-0280-y

C. Straka, D. Kim, and R. Timmerman, Ablation of a Site of Progression With Stereotactic Body Radiation Therapy Extends Sunitinib Treatment From 14 to 22 Months, Journal of Clinical Oncology, vol.31, issue.23, pp.401-403, 2013.
DOI : 10.1200/JCO.2012.47.7455

B. Pichon, F. Thillays, and C. Bourgier, Radioth??rapie st??r??otaxique hypofractionn??e des m??tastases osseuses, Cancer/Radioth??rapie, vol.18, issue.4, pp.342-349, 2014.
DOI : 10.1016/j.canrad.2014.04.005

W. Hall, L. Stapleford, and C. Hadjipanayis, Stereotactic Body Radiosurgery for Spinal Metastatic Disease: An Evidence-Based Review, International Journal of Surgical Oncology, vol.109, issue.2 c, p.979214, 2011.
DOI : 10.1016/S0167-8140(97)00097-2

S. Arrington, T. Damron, and K. Mann, Concurrent administration of zoledronic acid and irradiation leads to improved bone density, biomechanical strength, and microarchitecture in a mouse model of tumor-induced osteolysis, Journal of Surgical Oncology, vol.16, issue.3, pp.284-290, 2008.
DOI : 10.1002/jso.20949

P. Rose, I. Laufer, and P. Boland, Risk of Fracture After Single Fraction Image-Guided Intensity-Modulated Radiation Therapy to Spinal Metastases, Journal of Clinical Oncology, vol.27, issue.30, pp.5075-5079, 2009.
DOI : 10.1200/JCO.2008.19.3508

I. Lee, J. Seong, and C. Lee, Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions, International Journal of Radiation Oncology*Biology*Physics, vol.73, issue.5, pp.1517-1524, 2009.
DOI : 10.1016/j.ijrobp.2008.07.035

M. Milano, A. Katz, and H. Zhang, Oligometastases Treated With Stereotactic Body Radiotherapy: Long-Term Follow-Up of Prospective Study, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.3, pp.878-886, 2012.
DOI : 10.1016/j.ijrobp.2011.08.036

J. Salama, M. Hasselle, and S. Chmura, Stereotactic body radiotherapy for multisite extracranial oligometastases, Cancer, vol.366, issue.3 suppl, pp.2962-2970, 2012.
DOI : 10.1002/cncr.26611

C. Cleeland, The Measurement of Pain from Metastatic Bone Disease: Capturing the Patient's Experience, Clinical Cancer Research, vol.12, issue.20, pp.6236-6242, 2006.
DOI : 10.1158/1078-0432.CCR-06-0988

C. Cleeland, Symptom Burden: Multiple Symptoms and Their Impact as Patient-Reported Outcomes, JNCI Monographs, vol.2007, issue.37, pp.16-21, 2007.
DOI : 10.1093/jncimonographs/lgm005

J. Kirkpatrick, C. Kelsey, and M. Palta, Stereotactic body radiotherapy: A critical review for nonradiation oncologists, Cancer, vol.77, issue.suppl 3, pp.942-954, 2014.
DOI : 10.1002/cncr.28515